Skip to content

Nasdaq · CIK 0001412486

COCP Cocrystal Pharma, Inc.

Insider trading from SEC Form 4. Last filing Aug 6, 2026. Close $1.07 on Oct 9, 2026, +30% from the 52-week low and -32% from the high.

In brief

Cocrystal Pharma, Inc. (COCP) has 30 SEC Form 4 filings on file from 9 insiders, the latest filed on Aug 6, 2026. In the last 90 days insiders made 2 open-market buys worth $80k and 0 open-market sells worth $0, net +$80k.

9 open-market trades have been scored at COCP. The newest: Frost Phillip Md Et Al (director and 10% owner) bought $9,816 of stock on Aug 5, 2026, filed Aug 6, 2026, scored 18 (weak). The largest of the 9 shown: Frost Phillip Md Et Al (director and 10% owner) bought $71k on Aug 3, 2026, scored 26 (weak).

Last 90 days

Net insider value
+$80k
more bought than sold
Buys
2
$80k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Price and insider trades, last year

COCPOct 9, 2026 · close 1.07

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Cocrystal Pharma, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
18WeakFrost Phillip Md Et Al
director, owner
buy
$9,816
10,000 shares
+1%+24% from low-40% from high
26WeakFrost Phillip Md Et Al
director, owner
buy
$71k
75,000 shares
+4%+15% from low-52% from high
23WeakFrost Phillip Md Et Al
director, owner
buy
$20k
20,000 shares
+1%+16% from low-48% from high
29WeakFrost Phillip Md Et Al
director, owner
buy
$47k
50,000 shares
+3%+13% from low-57% from high
39WeakFrost Phillip Md Et Al
director, owner
buy
$47k
50,000 shares
+3%+9% from low-59% from high
33WeakFrost Phillip Md Et Al
director, owner
buy
$19k
20,000 shares
+1%+6% from low-71% from high
41ModerateFrost Phillip Md Et Al
director, owner
buy
$63k
65,000 shares
+4%+8% from low-70% from high
10WeakFrost Phillip Md Et Al
director, owner
buy
$3,975
4,000 shares
+0%-
10WeakFrost Phillip Md Et Al
director, owner
buy
$19k
20,000 shares
+1%-

Transactions

Every row filed, 36 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Aug 5, 2026Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+10,000$0.98$9,8161,993,551Aug 6, 2026
Aug 3, 2026Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+75,000$0.94$71k1,983,551Aug 5, 2026
Jun 3, 2026James Sapirstein
Chief Executive Officer
AGrant or award
Stock Options (Right to Buy)derivative
+235,000$0.00$0235,000Jun 3, 2026
Feb 24, 2026Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+20,000$1.00$20k1,908,551Feb 25, 2026
Feb 6, 2026Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+50,000$0.95$47k1,888,551Feb 9, 2026
Jan 9, 2026Sam Lee
President and Co-CEO
AGrant or award
Stock Options (Right to Buy)derivative
+49,229$0.00$049,229Jan 13, 2026
Jan 9, 2026Roger D. Kornberg
director
AGrant or award
Stock Options (Right to Buy)derivative
+24,615$0.00$024,615Jan 13, 2026
Jan 9, 2026Richard C Pfenniger Jr
director
AGrant or award
Stock Options (Right to Buy)derivative
+16,410$0.00$016,410Jan 13, 2026
Jan 9, 2026Fred Hassan
director
AGrant or award
Stock Options (Right to Buy)derivative
+16,410$0.00$016,410Jan 13, 2026
Jan 9, 2026James Joseph Martin
Co-CEO and CFO
AGrant or award
Stock Options (Right to Buy)derivative
+49,229$0.00$049,229Jan 13, 2026
Jan 9, 2026Frost Phillip Md Et Al
director, owner
AGrant or award
Stock Options (Right to Buy)derivative
+24,615$0.00$024,615Jan 13, 2026
Jan 9, 2026Anthony J Japour
director
AGrant or award
Stock Options (Right to Buy)derivative
+16,410$0.00$016,410Jan 13, 2026
Jan 9, 2026Steven D Rubin
director
AGrant or award
Stock Options (Right to Buy)derivative
+16,410$0.00$016,410Jan 13, 2026
Dec 31, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+50,000$0.95$47k1,838,551Jan 2, 2026
Dec 30, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+20,000$0.97$19k1,788,551Dec 31, 2025
Dec 24, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+25,000$0.97$24k1,728,551Dec 29, 2025
Dec 26, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+40,000$0.97$39k1,768,551Dec 29, 2025
Nov 26, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+1,500$1.00$1,5001,701,051Nov 28, 2025
Nov 26, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+2,500$0.99$2,4751,703,551Nov 28, 2025
Nov 25, 2025Frost Phillip Md Et Al
director, owner
POpen-market purchase
Common Stockindirect: By Frost Gamma Investments Trust
+20,000$0.94$19k1,699,551Nov 25, 2025
Oct 28, 2025James Joseph Martin
Co-CEO and CFO
AGrant or award
Common Stock
+3,598$1.39$5,00144,167Oct 30, 2025
Oct 28, 2025Richard C Pfenniger Jr
director
AGrant or award
Common Stock
+20,000--31,400Oct 30, 2025
Oct 28, 2025Fred Hassan
director
AGrant or award
Common Stock
+359,713$1.39$500k1,383,009Oct 30, 2025
Oct 28, 2025Frost Phillip Md Et Al
director, owner
AGrant or award
Common Stockindirect: By Frost Gamma Investments Trust
+359,713$1.39$500k1,679,551Oct 30, 2025
Oct 28, 2025James Joseph Martin
Co-CEO and CFO
AGrant or award
Warrantsderivative
+7,196$1.39$10k7,196Oct 30, 2025
Oct 28, 2025Richard C Pfenniger Jr
director
AGrant or award
Warrantsderivative
+40,000$1.39$56k40,000Oct 30, 2025
Oct 28, 2025Fred Hassan
director
AGrant or award
Warrantsderivative
+719,426$1.39$1.0M719,426Oct 30, 2025
Oct 28, 2025Frost Phillip Md Et Al
director, owner
AGrant or award
Warrantsderivativeindirect: By Frost Gamma Investments Trust
+719,426$1.39$1.0M719,426Oct 30, 2025
Oct 9, 2024Anthony J Japour
director
AGrant or award
Common Stock
+14,924--14,924Oct 11, 2024
Oct 9, 2024Fred Hassan
director
AGrant or award
Common Stock
+8,067--1,023,296Oct 11, 2024
Oct 9, 2024James Joseph Martin
Co-CEO and CFO
AGrant or award
Common Stock
+40,000--40,569Oct 11, 2024
Oct 9, 2024Frost Phillip Md Et Al
director, owner
AGrant or award
Common Stock
+27,100--27,100Oct 11, 2024
Oct 9, 2024Richard C Pfenniger Jr
director
AGrant or award
Common Stock
+8,067--11,400Oct 11, 2024
Oct 9, 2024Roger D. Kornberg
director
AGrant or award
Common Stock
+28,109--28,109Oct 11, 2024
Oct 9, 2024Sam Lee
President and Co-CEO
AGrant or award
Common Stock
+40,000--76,355Oct 11, 2024
Oct 9, 2024Steven D Rubin
director
AGrant or award
Common Stock
+18,957--2,660,242Oct 11, 2024

Insiders

Everyone who has filed a Form 4 here.

Questions about COCP

Answered from the filings on this page, as of the latest one.

Are insiders buying COCP?

As of Aug 6, 2026, SEC Form 4 filings show 2 open-market buys worth $80k by 1 insider and 0 open-market sells worth $0 by 0 insiders at Cocrystal Pharma, Inc. in the last 90 days, net +$80k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.

Who was the last insider to trade COCP on the open market?

Frost Phillip Md Et Al (director and 10% owner) bought $9,816 of COCP on Aug 5, 2026 and filed the Form 4 on Aug 6, 2026. InsiderTell scored 18 (weak).

How many insiders file Form 4 at Cocrystal Pharma, Inc.?

9 people have filed a Form 4 at Cocrystal Pharma, Inc., among them Frost Phillip Md Et Al (director, 10% owner, CEO and chair), Fred Hassan (director), Anthony J Japour (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

COCP insider trading: Cocrystal Pharma, Inc. | InsiderTell